Jame Abraham

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Ejection Fraction

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Metastatic Breast Cancer

Top Venues

JCO oncology practice

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Nerea Lopetegui Lia, Revati Varma, Jame Abraham, Erin Roesch
Current and Novel Treatment Options in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. JCO oncology practice (2024)
Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, Carley Mitchell, Paul G Pavicic, Pingfu Fu, Amit Rupani, Hana Husic, Patricia A Rayman, Shadi Swaidani, Jame Abraham, George T Budd, Halle C F Moore, Zahraa Al-Hilli, Jennifer Susan Ko, Joseph Baar, Timothy A Chan, Tyler J Alban, C Marcela Diaz-Montero, Alberto J Montero
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Nathaniel Braman, Prateek Prasanna, Kaustav Bera, Mehdi Alilou, Mohammadhadi Khorrami, Patrick Leo, Maryam Etesami, Manasa Vulchi, Paulette Turk, Amit Gupta, Prantesh Jain, Pingfu Fu, Nathan A Pennell, Vamsidhar Velcheti, Jame Abraham, Donna Plecha, Anant Madabhushi
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Erin Roesch, Jame Abraham
Reflection on Supportive Care Elements During the Metastatic Breast Cancer Journey. JCO oncology practice 17 (4) (2021)
Siddharth Kunte, Jame Abraham, Alberto J Montero
Novel HER2-targeted therapies for HER2-positive metastatic breast cancer. Cancer 126 (19) (2020)